During the past decade, Bowden Eye Associates conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bowden Eye Associates" #1 sponsor was "Allergan" with 2 trials, followed by "Santen Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored, "Claris Biotherapeutics, Inc." with 1 trials sponsored and "Formosa Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bowden Eye Associates" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bowden Eye Associates" are "Dry Eye" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Dry Eye Disease" (1 trials) and "Dry Eye Disease (DED)" (1 trials). Many other conditions were trialed in "Bowden Eye Associates" in a lesser frequency.

Most popular intervention types in "Bowden Eye Associates" are "Drug" (10 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lifitegrast 5% Ophthalmic Solution" (2 trials), "SHP640" (2 trials), "0.005% Lacripep" (1 trials) and "0.01% Lacripep" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bowden Eye Associates" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Bowden Eye Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Bowden Eye Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bowden Eye Associates, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".